High affinity adaptor molecules for redirecting antibody specifity

Details for Australian Patent Application No. 2010303636 (hide)

Owner Opsonic Therapeutics Inc.

Inventors Collinson, Albert; Wagner, Peter; Sallberg, Matti; Vahlne, Anders; Schurmann, Gregor; Kamen, Robert

Agent Davies Collison Cave

Pub. Number AU-A-2010303636

PCT Pub. Number WO2011/044133

Priority 61/248,778 05.10.09 US; 61/257,351 02.11.09 US

Filing date 5 October 2010

Wipo publication date 14 April 2011

International Classifications

C12N 15/115 (2010.01) Mutation or genetic engineering - Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith

C40B 40/00 (2006.01) Libraries , e.g. arrays, mixtures

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

19 April 2012 PCT application entered the National Phase

  PCT publication WO2011/044133 Priority application(s): WO2011/044133

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010303652-Anthroquinone containing derivatives as biochemical agricultural products

2010303635-Generation of haploid plants and improved plant breeding